サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1434509

中毒性疾患治療薬市場：薬物タイプ、治療法、エンドユーザー別-2024-2030年の世界予測

Addiction Disorders Drugs Market by Drug Type (Alcohol, Marijuana, Prescription & Over-the-Counter Medications), Treatment (Counseling & Behavioral Therapies, Detoxification, Medications), End-user - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
中毒性疾患治療薬市場：薬物タイプ、治療法、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中毒性疾患治療薬市場規模は2023年に254億6,000万米ドルと推計され、2024年には270億8,000万米ドルに達し、CAGR 6.46%で2030年には394億7,000万米ドルに達すると予測されます。

中毒性疾患治療薬の世界市場

主な市場の統計
基準年[2023］ 254億6,000万米ドル
予測年[2024] 270億8,000万米ドル
予測年 [2030] 394億7,000万米ドル
CAGR（%） 6.46%
中毒性疾患治療薬 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは中毒性疾患治療薬市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、中毒性疾患治療薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-中毒性疾患治療薬市場の市場規模および予測は？

2-中毒性疾患治療薬市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-中毒性疾患治療薬市場における技術動向と規制の枠組みは？

4-中毒性疾患治療薬市場における主要ベンダーの市場シェアは？

5-中毒性疾患治療薬市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • あらゆる年齢層でアルコール、タバコ、薬物などの依存性物質の蔓延が増加
      • 依存症を抑制するための政府の介入と奨励
      • 承認された医薬品の数の増加と、他の興奮剤との併用によるニコチンの使用の増加
    • 抑制要因
      • 新興諸国における依存症治療製品に関する認知度は限られている
      • メサドンの使用に伴う複数の副作用
    • 機会
      • 錠剤、舌下フィルム、インプラントなどの革新的な医薬品の入手可能性
    • 課題
      • 依存症治療薬に対する法的義務
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 中毒性疾患治療薬市場薬剤の種類別

  • アルコール
  • マリファナ
  • 処方薬と市販薬
  • 合成カンナビノイド
  • タバコ/ニコチンと電子タバコ

第7章 中毒性疾患治療薬市場治療別

  • カウンセリングと行動療法
  • 解毒
  • 薬
  • リハビリテーションプログラム
  • 自助グループ

第8章 中毒性疾患治療薬市場：エンドユーザー別

  • 病院とクリニック
  • 住宅治療センター

第9章 南北アメリカの中毒性疾患治療薬市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の中毒性疾患治療薬市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの中毒性疾患治療薬市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Accord Healthcare Limited
    • Alkermes PLC
    • Aurobindo Pharma Limited
    • BioCorRx Inc.
    • Cipla Limited
    • Consern Pharma Limited
    • GlaxoSmithKline PLC
    • Insys Therapeutics
    • Mallinckrodt Pharmaceuticals
    • Medtronic PLC
    • Novartis AG
    • Perrigo Company PLC
    • Pfizer, Inc
    • Psychemedics Corporation
    • Purdue Pharma L.P.
    • Reckitt Benckiser Pharmaceuticals, Inc.
    • Sun Pharmaceutical Industries Limited
    • Takeda Pharmaceutical Company Ltd
    • Teva Pharmaceutical Industries, Ltd
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ADDICTION DISORDERS DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ADDICTION DISORDERS DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ADDICTION DISORDERS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ADDICTION DISORDERS DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ADDICTION DISORDERS DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ADDICTION DISORDERS DRUGS MARKET DYNAMICS
  • FIGURE 7. ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 10. ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ADDICTION DISORDERS DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. ADDICTION DISORDERS DRUGS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ADDICTION DISORDERS DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ADDICTION DISORDERS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ADDICTION DISORDERS DRUGS MARKET SIZE, BY MARIJUANA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRESCRIPTION & OVER-THE-COUNTER MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ADDICTION DISORDERS DRUGS MARKET SIZE, BY SYNTHETIC CANNABINOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ADDICTION DISORDERS DRUGS MARKET SIZE, BY TOBACCO/NICOTINE & VAPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 12. ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNSELING & BEHAVIORAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ADDICTION DISORDERS DRUGS MARKET SIZE, BY DETOXIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ADDICTION DISORDERS DRUGS MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ADDICTION DISORDERS DRUGS MARKET SIZE, BY REHABILITATION PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ADDICTION DISORDERS DRUGS MARKET SIZE, BY SELF-HELP GROUPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. ADDICTION DISORDERS DRUGS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ADDICTION DISORDERS DRUGS MARKET SIZE, BY RESIDENTIAL TREATMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. ADDICTION DISORDERS DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 148. ADDICTION DISORDERS DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. ADDICTION DISORDERS DRUGS MARKET LICENSE & PRICING
目次
Product Code: MRR-434CCDA05186

[193 Pages Report] The Addiction Disorders Drugs Market size was estimated at USD 25.46 billion in 2023 and expected to reach USD 27.08 billion in 2024, at a CAGR 6.46% to reach USD 39.47 billion by 2030.

Global Addiction Disorders Drugs Market

KEY MARKET STATISTICS
Base Year [2023] USD 25.46 billion
Estimated Year [2024] USD 27.08 billion
Forecast Year [2030] USD 39.47 billion
CAGR (%) 6.46%
Addiction Disorders Drugs Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Addiction Disorders Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Addiction Disorders Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Addiction Disorders Drugs Market, highlighting leading vendors and their innovative profiles. These include Accord Healthcare Limited, Alkermes PLC, Aurobindo Pharma Limited, BioCorRx Inc., Cipla Limited, Consern Pharma Limited, GlaxoSmithKline PLC, Insys Therapeutics, Mallinckrodt Pharmaceuticals, Medtronic PLC, Novartis AG, Perrigo Company PLC, Pfizer, Inc, Psychemedics Corporation, Purdue Pharma L.P., Reckitt Benckiser Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited, Takeda Pharmaceutical Company Ltd, and Teva Pharmaceutical Industries, Ltd.

Market Segmentation & Coverage

This research report categorizes the Addiction Disorders Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Drug Type
    • Alcohol
    • Marijuana
    • Prescription & Over-the-Counter Medications
    • Synthetic Cannabinoids
    • Tobacco/Nicotine & Vaping
  • Treatment
    • Counseling & Behavioral Therapies
    • Detoxification
    • Medications
    • Rehabilitation Programs
    • Self-Help Groups
  • End-user
    • Hospital & Clinics
    • Residential Treatment Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Addiction Disorders Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Addiction Disorders Drugs Market?

3. What are the technology trends and regulatory frameworks in the Addiction Disorders Drugs Market?

4. What is the market share of the leading vendors in the Addiction Disorders Drugs Market?

5. Which modes and strategic moves are suitable for entering the Addiction Disorders Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Addiction Disorders Drugs Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalences of addictive substances such as alcohol, tobacco, and drugs among all age groups
      • 5.1.1.2. Government intervention and encouragement to curb addiction disorders
      • 5.1.1.3. Rising number of approved medicines and the increased use of nicotine with other stimulants
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness about addiction treatment products in developing countries
      • 5.1.2.2. Multiple side-effects associated with the use of methadone
    • 5.1.3. Opportunities
      • 5.1.3.1. Availability of innovative drugs in the form of pills, sublingual films, and implants
    • 5.1.4. Challenges
      • 5.1.4.1. Legal obligations for addiction treatment products
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Addiction Disorders Drugs Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Alcohol
  • 6.3. Marijuana
  • 6.4. Prescription & Over-the-Counter Medications
  • 6.5. Synthetic Cannabinoids
  • 6.6. Tobacco/Nicotine & Vaping

7. Addiction Disorders Drugs Market, by Treatment

  • 7.1. Introduction
  • 7.2. Counseling & Behavioral Therapies
  • 7.3. Detoxification
  • 7.4. Medications
  • 7.5. Rehabilitation Programs
  • 7.6. Self-Help Groups

8. Addiction Disorders Drugs Market, by End-user

  • 8.1. Introduction
  • 8.2. Hospital & Clinics
  • 8.3. Residential Treatment Centers

9. Americas Addiction Disorders Drugs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Addiction Disorders Drugs Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Addiction Disorders Drugs Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Accord Healthcare Limited
    • 13.1.2. Alkermes PLC
    • 13.1.3. Aurobindo Pharma Limited
    • 13.1.4. BioCorRx Inc.
    • 13.1.5. Cipla Limited
    • 13.1.6. Consern Pharma Limited
    • 13.1.7. GlaxoSmithKline PLC
    • 13.1.8. Insys Therapeutics
    • 13.1.9. Mallinckrodt Pharmaceuticals
    • 13.1.10. Medtronic PLC
    • 13.1.11. Novartis AG
    • 13.1.12. Perrigo Company PLC
    • 13.1.13. Pfizer, Inc
    • 13.1.14. Psychemedics Corporation
    • 13.1.15. Purdue Pharma L.P.
    • 13.1.16. Reckitt Benckiser Pharmaceuticals, Inc.
    • 13.1.17. Sun Pharmaceutical Industries Limited
    • 13.1.18. Takeda Pharmaceutical Company Ltd
    • 13.1.19. Teva Pharmaceutical Industries, Ltd
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing